top of page

Modality profile: Radiotherapies at #ASCO23 with Dr. Phil Kantoff

Convergent Therapeutics CEO Phil Kantoff describes the use of targeted radiotherapies against cancer. #ASCO23



Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page